Literature DB >> 7851762

Neurospora mutants affecting polyamine-dependent processes and basic amino acid transport mutants resistant to the polyamine inhibitor, alpha-difluoromethylornithine.

R H Davis1, P Lieu, J L Ristow.   

Abstract

Polyamines (spermidine and spermine) are required by living cells, but their functions are poorly understood. Mutants of Neurospora crassa with enhanced or diminished sensitivity to interference with polyamine synthesis, originally selected to study the regulation of the pathway, were found to have unexpected defects. A group of four non-allelic mutations, causing no interference with polyamine synthesis, each imparted spermidine auxotrophy to a genotype already partially impaired in spermidine synthesis. Strains carrying only the new mutations displayed unconditional delay or weakness at the onset of growth, but grew well thereafter and had a normal or overly active polyamine pathway. These mutants may have defects in vital macromolecular activities that are especially dependent upon the polyamines-activities that have not been identified with certainty in studies to date. Another group of mutants, selected as resistant to the polyamine inhibitor difluoromethylornithine (DFMO), had normal activity and regulation of ornithine decarboxylase, the target of the drug. All but one of thirty mutants were allelic, and were specifically deficient in the basic amino acid permease. This mechanism of DFMO resistance is unprecedented among the many DFMO-resistant cell types of other organisms and demonstrates that DFMO can be used for efficient genetic studies of this transport locus in N. crassa.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7851762      PMCID: PMC1206215     

Source DB:  PubMed          Journal:  Genetics        ISSN: 0016-6731            Impact factor:   4.562


  12 in total

Review 1.  Recent advances in the biochemistry of polyamines in eukaryotes.

Authors:  A E Pegg
Journal:  Biochem J       Date:  1986-03-01       Impact factor: 3.857

Review 2.  Chromosomal loci of Neurospora crassa.

Authors:  D D Perkins; A Radford; D Newmeyer; M Björkman
Journal:  Microbiol Rev       Date:  1982-12

3.  Streptomycin resistance (rpsL) produces an absolute requirement for polyamines for growth of an Escherichia coli strain unable to synthesize putrescine and spermidine [delta(speA-speB) delta specC].

Authors:  H Tabor; C W Tabor; M S Cohn; E W Hafner
Journal:  J Bacteriol       Date:  1981-08       Impact factor: 3.490

Review 4.  Sequestered end products and enzyme regulation: the case of ornithine decarboxylase.

Authors:  R H Davis; D R Morris; P Coffino
Journal:  Microbiol Rev       Date:  1992-06

5.  Pyrimidine synthesis in Neurospora crassa: gene-enzyme relationships.

Authors:  D F Caroline
Journal:  J Bacteriol       Date:  1969-12       Impact factor: 3.490

6.  Nonsense mutations of the ornithine decarboxylase structural gene of Neurospora crassa.

Authors:  R H Davis; L V Hynes; P Eversole-Cire
Journal:  Mol Cell Biol       Date:  1987-03       Impact factor: 4.272

7.  Arginaseless Neurospora: genetics, physiology, and polyamine synthesis.

Authors:  R H Davis; M B Lawless; L A Port
Journal:  J Bacteriol       Date:  1970-05       Impact factor: 3.490

8.  Uptake, intracellular binding, and excretion of polyamines during growth of Neurospora crassa.

Authors:  R H Davis; J L Ristow
Journal:  Arch Biochem Biophys       Date:  1989-06       Impact factor: 4.013

9.  Polyamine transport in Neurospora crassa.

Authors:  R H Davis; J L Ristow
Journal:  Arch Biochem Biophys       Date:  1988-12       Impact factor: 4.013

10.  Regulation of polyamine synthesis in relation to putrescine and spermidine pools in Neurospora crassa.

Authors:  T J Paulus; R H Davis
Journal:  J Bacteriol       Date:  1981-01       Impact factor: 3.490

View more
  1 in total

Review 1.  Human African trypanosomiasis: pharmacological re-engagement with a neglected disease.

Authors:  M P Barrett; D W Boykin; R Brun; R R Tidwell
Journal:  Br J Pharmacol       Date:  2007-07-09       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.